This is evidenced by the cancer predisposition associated with germline mutations in BRCA1, BRCA2, and other HR genes [35,36], as well as by the frequent somatic suppression of HR observed in sporadic cancers, where it acts as a driver of tumorigenesis [37,38,39]. The gene discussed is BRCA2; the disease is cancer.